![Alfonso Quintás-Cardama](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alfonso Quintás-Cardama
Chief Tech/Sci/R&D Officer at
FOGHORN THERAPEUTICS INC.
Net worth: - $ as of 31/05/2026
Profile
Alfonso Quintás-Cardama currently works at Foghorn Therapeutics, Inc., as Chief Medical Officer from 2023.
Dr. Quintás-Cardama also formerly worked at GSK Plc, as Head-Cell & Gene Therapies Unit, The University of Texas M.D.
Anderson Cancer Center, as Assistant Professor from 2009 to 2014, and TCR² Therapeutics, Inc., as Chief Medical Officer.
Dr. Quintás-Cardama received his doctorate degree from the University of Santiago de Compostela.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 20/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Alfonso Quintás-Cardama active positions
| Companies | Position | Start |
|---|---|---|
| FOGHORN THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 11/09/2023 |
Former positions of Alfonso Quintás-Cardama
| Companies | Position | End |
|---|---|---|
The University of Texas M.D. Anderson Cancer Center
 The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services Provides cancer patient care, research and prevention for cancer | Corporate Officer/Principal | 01/01/2014 |
| GSK PLC | Corporate Officer/Principal | - |
| TCR2 THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | - |
Training of Alfonso Quintás-Cardama
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
4
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
The University of Texas M.D. Anderson Cancer Center
The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services Provides cancer patient care, research and prevention for cancer | Consumer Services |
University of Santiago de Compostela
 University of Santiago de Compostela Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TCR2 Therapeutics, Inc.
 TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage cell therapy company which engages in the development of biological drugs and engineering T-cells for cancer therapy | Health Technology |
Foghorn Therapeutics, Inc.
 Foghorn Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops novel drugs to treat cancer and other serious medical disorders | Health Technology |
- Stock Market
- Insiders
- Alfonso Quintás-Cardama
